Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Acute, adapted, Adjunctive, Alexander, alter, arena, arm, Asia, assault, Atlanta, attorney, auriclosene, Baltimore, baynovation, began, Britain, Brunei, burn, Cambodia, cap, Chlorine, circulatory, coinciding, Concurrently, crowded, De, dealt, Dermnovation, distributor, dof, donor, Dright, East, environment, evolutionary, evolved, exceeded, facilitate, Farideh, Fleming, FTE, Ga, gearing, golden, graft, hinder, HOCl, Indonesia, INN, innate, insight, invasive, isolation, istributor, Jan, juice, jurisdiction, Lohman, MAA, Malaysia, mammal, Md, Merton, Mkt, Molnlycke, Myanmar, Naqu, necrotizing, nomenclature, nonproprietary, Northern, NPWT, OmniPhase, Pacific, penicillin, perception, pivotal, programmatic, pronounced, pump, reallocate, refundable, reorganized, Roucher, sample, SE, segregate, SFDA, Sir, slightly, spray, Spring, Sr, structure, surprise, technique, Thailand, thirteen, thrived, thrown, traditional, underwritten, unique, unregistered, Urovation, ushered, Vietnam, vitro, widened, wife, withholding
Filing tables
Filing exhibits
NBY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-180461, 333-147334, 333-157041, 333-164469, 333-171981 and 333-185998) and on Form S-3 (File Nos. 333-159917 and 333-180460) of our report dated March 11, 2013, relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2012.
/s/ OUM & Co. LLP
San Francisco, California
March 11, 2013